P. Dieringer

600 total citations
10 papers, 501 citations indexed

About

P. Dieringer is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, P. Dieringer has authored 10 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in P. Dieringer's work include Prostate Cancer Treatment and Research (9 papers), Cancer Treatment and Pharmacology (4 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). P. Dieringer is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Cancer Treatment and Pharmacology (4 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). P. Dieringer collaborates with scholars based in United States and Spain. P. Dieringer's co-authors include Christopher J. Logothetis, Lance C. Pagliaro, Juan Herrada, Danai Daliani, Christos N. Papandreou, Julian Adams, Randall E. Millikan, Darrell Nix, Dixie Esseltine and Hong Yang and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Journal of Urology.

In The Last Decade

P. Dieringer

10 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Dieringer United States 7 299 203 158 150 76 10 501
Karl Hsu United States 7 255 0.9× 168 0.8× 80 0.5× 101 0.7× 82 1.1× 14 433
Roelof Koster Netherlands 11 351 1.2× 210 1.0× 85 0.5× 79 0.5× 118 1.6× 23 672
Mark Dowar Canada 9 214 0.7× 144 0.7× 45 0.3× 81 0.5× 146 1.9× 12 460
Ying‐Ming Jou United States 9 296 1.0× 385 1.9× 112 0.7× 317 2.1× 22 0.3× 21 574
Randi Utne Holt Norway 10 338 1.1× 160 0.8× 30 0.2× 217 1.4× 64 0.8× 13 527
Hiroyuki Maeta Japan 11 191 0.6× 146 0.7× 79 0.5× 23 0.2× 96 1.3× 24 419
Sabrina Coluzzi Italy 7 275 0.9× 111 0.5× 38 0.2× 127 0.8× 267 3.5× 7 584
Benjamin J. Gigliotti United States 7 106 0.4× 188 0.9× 93 0.6× 77 0.5× 28 0.4× 18 392
Giulia Orlando Italy 10 322 1.1× 121 0.6× 49 0.3× 32 0.2× 76 1.0× 30 484
Heike Allgayer Germany 8 136 0.5× 241 1.2× 68 0.4× 98 0.7× 234 3.1× 8 500

Countries citing papers authored by P. Dieringer

Since Specialization
Citations

This map shows the geographic impact of P. Dieringer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Dieringer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Dieringer more than expected).

Fields of papers citing papers by P. Dieringer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Dieringer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Dieringer. The network helps show where P. Dieringer may publish in the future.

Co-authorship network of co-authors of P. Dieringer

This figure shows the co-authorship network connecting the top 25 collaborators of P. Dieringer. A scholar is included among the top collaborators of P. Dieringer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Dieringer. P. Dieringer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Zurita, Amado J., Louis L. Pisters, Patricia Troncoso, et al.. (2015). Integrating chemohormonal therapy and surgery in known or suspected lymph node metastatic prostate cancer. Prostate Cancer and Prostatic Diseases. 18(3). 276–280. 6 indexed citations
2.
Zurita, Amado J., John F. Ward, John C. Araujo, et al.. (2011). Neoadjuvant trial of sunitinib malate and androgen ablation (ADT) in patients with localized prostate cancer (PCa) at high risk for recurrence.. Journal of Clinical Oncology. 29(7_suppl). 143–143. 5 indexed citations
3.
Zurita, Amado J., John F. Ward, John C. Araujo, et al.. (2008). Presurgical sunitinib malate and androgen ablation in patients with localized prostate cancer at high risk for recurrence. Journal of Clinical Oncology. 26(15_suppl). 16004–16004. 5 indexed citations
4.
5.
Mathew, Paul, Christopher J. Logothetis, P. Dieringer, et al.. (2006). Thalidomide/Estramustine/Paclitaxel in Metastatic Androgen-Independent Prostate Cancer. Clinical Genitourinary Cancer. 5(2). 144–149. 10 indexed citations
6.
Papandreou, Christos N., Danai Daliani, Darrell Nix, et al.. (2004). Phase I Trial of the Proteasome Inhibitor Bortezomib in Patients With Advanced Solid Tumors With Observations in Androgen-Independent Prostate Cancer. Journal of Clinical Oncology. 22(11). 2108–2121. 372 indexed citations
7.
Daliani, Danai, P. Dieringer, L. Pagliaro, et al.. (2003). 868 A tolerance and efficacy study of thalidomide, paclitaxel, estramustine combination for patients with chemotherapy refractory androgen independent prostate carcinoma. European Journal of Cancer Supplements. 1(5). S261–S261. 1 indexed citations
8.
Papandreou, Christos N., Danai Daliani, Randall E. Millikan, et al.. (2001). Inhibition of 20S proteasome results in serum IL-6 and PSA decline in patients (pts) with androgen-independent prostate cancer (AIPCa) treated with the proteasome inhibitor PS-341. European Journal of Cancer. 37. S144–S144. 16 indexed citations
9.
Herrada, Juan, P. Dieringer, & Christopher J. Logothetis. (1996). Characterization of Patients with Androgen-Independent Prostatic Carcinoma Whose Serum Prostate Specific Antigen Decreased Following Flutamide Withdrawal. The Journal of Urology. 155(2). 620–623. 37 indexed citations
10.
Herrada, Juan, P. Dieringer, & Christopher J. Logothetis. (1996). Characterization of patients with androgen-independent prostatic carcinoma whose serum prostate specific antigen decreased following flutamide withdrawal.. PubMed. 155(2). 620–3. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karl Hsu Breakdown of academic impact, for papers by Roelof Koster Breakdown of academic impact, for papers by Mark Dowar Breakdown of academic impact, for papers by Ying‐Ming Jou Breakdown of academic impact, for papers by Randi Utne Holt Breakdown of academic impact, for papers by Hiroyuki Maeta Breakdown of academic impact, for papers by Sabrina Coluzzi Breakdown of academic impact, for papers by Benjamin J. Gigliotti Breakdown of academic impact, for papers by Giulia Orlando Breakdown of academic impact, for papers by Heike Allgayer
Rankless by CCL
2026